HIV Post Exposure Prophylaxis: prospects, opportunities and challenges by Julie Fox, Euphemia L. Sibanda, Peter Godfrey‐Faussett

Get full text

Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post‐exposure prophylaxis containing a tenofovir/emtricitabine backbone by Lanxin Zhang, Simon Collins, Julie Fox, Max vonKleist

Get full text

Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective... by Sylvia Kusemererwa, Sheila Kansiime, Sarah Nakamanya, Elizabeth Mbabazi, Julie Fox, Sheena McCormack, Pontiano Kaleebu, Eugene Ruzagira

Get full text

Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm by Sheila Kansiime, Christian Holm Hansen, Henry Bern, Julie Fox, David Dunn, Eugene Ruzagira, Richard Hayes, Sheena Mc Cormack, on behalf of the PrEPVacc study team

Get full text

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. by Matthew Pace, James Williams, Ayako Kurioka, Andrew B Gerry, Bent Jakobsen, Paul Klenerman, Nneka Nwokolo, Julie Fox, Sarah Fidler, John Frater, CHERUB Investigators

Get full text

Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucl... by Collins Iwuji, Laura Waters, Ana Milinkovic, Chloe Orkin, Julie Fox, Frank Post, Nicky Perry, Chloe Bruce, Natalie Dailey, Ye To, Stephen Bremner, Duncan Churchill, Anna Maria Geretti

Get full text

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK. by Jamie Inshaw, Clifford Leen, Martin Fisher, Richard Gilson, David Hawkins, Simon Collins, Julie Fox, Ken McLean, Sarah Fidler, Andrew Phillips, Sam Lattimore, Abdel Babiker, Kholoud Porter, UK HIV Seroconverters Cohort

Get full text

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern. by Carl Graham, Thomas Lechmere, Aisha Rehman, Jeffrey Seow, Ashwini Kurshan, Isabella Huettner, Thomas J A Maguire, Jerry C H Tam, Daniel Cox, Christopher Ward, Mariusz Racz, Anele Waters, Christine Mant, Michael H Malim, Julie Fox, Katie J Doores

Get full text

Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection. by Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, Stephen Hickling, Jacob Hurst, Jodi Meyerowitz, Christian B Willberg, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, Abdel Babiker, Jonathan Weber, Nneka Nwokolo, Julie Fox, Sarah Fidler, Rodney Phillips, John Frater, SPARTAC and CHERUB Investigators

Get full text

Corrigendum to “Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV” [Kidney International Reports Volume 7, Issue 4, April 20... by Rachel K.Y. Hung, Elizabeth Binns-Roemer, John W. Booth, Rachel Hilton, Mark Harber, Beatriz Santana-Suarez, Lucy Campbell, Julie Fox, Andrew Ustianowski, Catherine Cosgrove, James E. Burns, Amanda Clarke, David A. Price, David Chadwick, Denis Onyango, Lisa Hamzah, Kate Bramham, Caroline A. Sabin, Cheryl A. Winkler, Frank A. Post

Get full text

Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study. by Mitzy Gafos, Elizabeth Brodnicki, Monica Desai, Sheena McCormack, Will Nutland, Sonali Wayal, Ellen White, Gemma Wood, Tristan Barber, Gill Bell, Amanda Clarke, David Dolling, David Dunn, Julie Fox, Lewis Haddow, Charles Lacey, Anthony Nardone, Killian Quinn, Caroline Rae, Iain Reeves, Michael Rayment, David White, Vanessa Apea, Wilbert Ayap, Claire Dewsnap, Yolanda Collaco-Moraes, Gabriel Schembri, Yinka Sowunmi, Rob Horne, PROUD Study Team

Get full text

HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa by Giuseppe Pantaleo, Glenda Gray, Pontiano Kaleebu, Said Aboud, David Dunn, Merlin Robb, Janet Seeley, Sheena McCormack, Julie Fox, Jim Rooney, Tom Miller, Agricola Joachim, Ilesh Jani, Mary Amondi, Peter Hughes, Sarah Joseph, Eugene Ruzagira, Vincent Basajja, Jonathan Weber, Cherry Kingsley, Eligius Lyamuya, Lucas Maganga, Doreen Pamba, Edna Viegas, Charlotta Nilsson, Arne Kroidl, Angela Crook, Anne Gumbe, Phindile Khanyile, Jennifer Serwanga, Carter Lee, Kundai Chinyenze, Song Ding, Muhammad Bakari, Neetha Morar, Ayoub Kakande, Tumaini Nagu, Henry Bern, Sylvia Kusemererwa, Patricia Munseri, Lwitiho Sudi, Jorge Ribeiro, Igor Capitine, Diana Faini, Edna Nhacule, Kubashni Woeber, Yolanda Manganhe, Abisai Kisinda, Wiston William, Rujeko Samanthia Chimukuche, Londiwe Shandu, Silindile Zulu, Nishanta Singh, Zakir Gaffoor, Rachel Kawuma, Thandiwe Sithole, Samantha Siva, Eldinah Hwengwere, Rujeko Samanthia Chidawanyika, Nteboheleng Mahapa, Isabel Remane, Odete Bule, Patricia Ramgi, Raquel Chissumba, Eduardo Namalango, Carmelia Massingue, Emmanuel Kapesa, Elizabeth Danstan, Marco Missanga, Amani Kway, Lilian Njovu, Revocatus Kunambi, Frank Msafiri, Edith Tarimo, Deus Buma, Freddie Mukasa Kibengo, Christian Hansen Holmes, Sheila Kansiime, Sylvia Masawi, Tobias Vudriko, Shamim Nabukenya, Gertrude Mutonyi, Rita Nakiboneka, Susan Mugaba, Aminata Sy, Liz Brodnicki, Claire Wenden, Jacqueline Musau, Mabela Matsoso, Paramesh Chetty, Gustavo Doncel, Allison Matthews

Get full text